Clinical trial
Efficacy and Cost Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Locally Advanced Head and Neck Cancer to Prevent Aspiration Pneumonia. A Randomized Phase II-III Study
NCT01598402 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Cost Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Locally Advanced Head and Neck Cancer to Prevent Aspiration Pneumonia. A Randomized Phase II-III Study
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- December 31, 2011
- Completion date
- December 31, 2014
- Enrollment
- 106 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer